Skip to content

A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01629407
Enrollment
315
Registered
2012-06-27
Start date
2009-06-30
Completion date
2013-05-31
Last updated
2013-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Open-Angle

Brief summary

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Interventions

OTHERStandard of Care

Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.

Sponsors

Allergan
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Glaucoma in one or both eyes

Exclusion criteria

* Participation in a glaucoma therapeutic clinical trial

Design outcomes

Primary

MeasureTime frame
Change from Baseline in Visual FieldBaseline, 24 Months

Secondary

MeasureTime frame
Change from Baseline in Intraocular Pressure (IOP)Baseline, 24 Months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026